Clinical Trial Update: A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing SHR-A2009 with platinum-based chemotherapy in EGFR-mutated advanced or metastatic non-small cell lung cancer; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• SHR-A2009

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING